Atomo Diagnostics raising after shares climb 136pc
Listed medical device maker Atomo Diagnostics had its broker Bell Potter drumming up interest in an equity raising.
Source: afr.com
Stay updated with breaking news from Atomo Pascal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Listed medical device maker Atomo Diagnostics had its broker Bell Potter drumming up interest in an equity raising.
Under a new commercialisation agreement, Atomo Diagnostics (ASX: AT1) and NG Biotech will launch a unique blood-based rapid pregnancy tests across Australia, New Zealand, Canada and the United States.